AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Elementis PLC

Capital/Financing Update Sep 7, 2020

4640_bfr_2020-09-07_59b19098-9a3b-40cd-af1e-9a7b29f7575d.html

Capital/Financing Update

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 1439Y

Elementis PLC

07 September 2020

Elementis plc

Covenant update

Elementis plc ("Elementis" or the "Group"), a global specialty chemicals company, announces that the relaxation of the Group net debt/EBITDA* banking covenant to 3.75x, agreed in Q1 2020 as part of the Group's response to COVID-19, has now been extended to include the two testing points in 2021 (i.e. 30 June and 31 December). The arrangement costs are immaterial. 

Group trading in July and August was consistent with the trends outlined at the 2020 interim results on the 28 July and the Group is on track to deliver a significant reduction in net debt in the second half of 2020. A Q3 trading update is scheduled for 28 October.

Enquiries

Elementis plc

Ralph Hewins, CFO                                                                     Tel: 020 7067 2988

James Curran, Investor Relations                                             Tel: 020 7067 2994

Tulchan           

Martin Robinson                                                                         Tel: 020 7353 4200

David Allchurch

Note: *Pre IFRS 16

This announcement contains inside information as defined in EU Regulation No. 596/2014 and is in accordance with the Company's obligations under Article 17 of that Regulation. The person responsible for arranging the release of this announcement on behalf of Elementis plc is Laura Higgins, Company Secretary. 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

UPDEAPNLEAKEEFA

Talk to a Data Expert

Have a question? We'll get back to you promptly.